# MGRX — Mangoceuticals Inc · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** MGRX  
**Sources:** 17  
**Published:** 2026-08-03  
**Canonical:** https://app.k3vl4r.com/research/deep-research-mgrx-mangoceuticals-inc-catalysts-narrative-risks-1434

---

## Snapshot (as of Nov 9–10, 2026)

Mangoceuticals, Inc. (NASDAQ: MGRX) is a microcap men's (and women's) wellness telemedicine company headquartered in Dallas, Texas, founded in 2021 and described as an affiliate of Cohen Enterprises, Inc. [[10]](https://www.tickergate.com/stocks/mgrx)[[15]](https://stockanalysis.com/stocks/mgrx/)[[17]](https://www.stocktitan.net/overview/MGRX/). On its last trading print, the stock closed at ~$0.197 (+3.63%) on November 9, with a market capitalization of roughly $4.38 million, a 52-week range of ~$0.16–$2.41, and a beta of 2.15 [[7]](https://finance.yahoo.com/quote/MGRX/news/)[[10]](https://www.tickergate.com/stocks/mgrx)[[13]](https://stockanalysis.com/stocks/mgrx/statistics/)[[14]](https://finance.yahoo.com/quote/MGRX/). Over the trailing year the shares fell approximately 91%, and were down about 73% year-to-date versus an S&P 500 gain, underscoring the asset's extreme volatility and underperformance [[7]](https://finance.yahoo.com/quote/MGRX/news/)[[13]](https://stockanalysis.com/stocks/mgrx/statistics/)[[14]](https://finance.yahoo.com/quote/MGRX/). It trades on the Nasdaq Capital Market [[17]](https://www.stocktitan.net/overview/MGRX/).

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-mgrx-mangoceuticals-inc-catalysts-narrative-risks-1434 (free to sign up)._
